International Biotechnology Trust PLC Mirati Therapeutics, Inc. Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

A detailed history of International Biotechnology Trust PLC transactions in Mirati Therapeutics, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 216,000 shares of MRTX stock, worth $0. This represents 3.19% of its overall portfolio holdings.

Number of Shares

216,000

Previous 260,000 16.92%

Holding current value

Previous $9.39 Million 0.16%

% of portfolio

3.19%

Previous 2.93%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$27.8 - $45.35 $1.22 Million - $2 Million	-44,000 Reduced 16.92%	216,000 $9.41 Million
Q2 2023 Aug 08, 2023	BUY	$36.13 - $49.49 $578,080 - $791,840	16,000 Added 6.56%	260,000 $9.39 Million
Q4 2022 Feb 01, 2023	BUY	$41.27 - $98.62 $4.46 Million - $10.7 Million	108,000 Added 79.41%	244,000 $11.1 Million
Q3 2022 Nov 08, 2022	BUY	$59.5 - $86.7 $7.55 Million - $11 Million	126,869 Added 1389.43%	136,000 $9.5 Million
Q2 2022 Aug 16, 2022	SELL	$39.16 - $88.71 $7.02 Million - $15.9 Million	-179,369 Reduced 95.16%	9,131 $136 Million

Q1 2022 May 20, 2022	BUY	$75.82 - $150.97 $4.7 Million - $9.36 Million	62,000 Added 49.01%	188,500 $15.5 Million
Q4 2021 Feb 15, 2022	BUY	$132.01 - $190.29 $3.7 Million - $5.33 Million	28,000 Added 28.43%	126,500 $18.5 Million
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $10.8 Million - $14.5 Million	81,600 Added 482.84%	98,500 $17.4 Million
Q2 2021 Aug 11, 2021	SELL	$144.0 - $179.73 $7.27 Million - $9.08 Million	-50,500 Reduced 74.93%	16,900 $2.73 Million
Q4 2020 Feb 19, 2021	BUY	$162.05 - $240.27 $6.56 Million - $9.73 Million	40,500 Added 150.56%	67,400 $14.8 Million
Q3 2020 Dec 01, 2020	SELL	$113.26 - $167.27 $1.93 Million - $2.84 Million	-17,000 Reduced 38.72%	26,900 $4.46 Million
Q1 2020 May 18, 2020	BUY	$69.78 - $116.21 $558,240 - $929,680	8,000 Added 22.28%	43,900 $3.37 Million
Q4 2019 May 18, 2020	BUY	$70.76 - $128.86 $1.77 Million - $3.22 Million	25,000 Added 229.36%	35,900 $4.63 Million
Q2 2019 Aug 14, 2019	SELL	$59.49 - $104.71 $642,492 - $1.13 Million	-10,800 Reduced 49.77%	10,900 $1.12 Million
Q1 2019 May 14, 2019	BUY	$43.65 - $78.95 $947,205 - $1.71 Million	21,700 New	21,700 $1.59 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account

International Biotechnology Trust PLC Mirati Therapeutics, Inc. Transaction History